Literature DB >> 6238613

Continuous wave Doppler velocimetry as an adjunct to cross sectional echocardiography in the diagnosis of critical left heart obstruction in neonates.

P J Robinson, R K Wyse, J E Deanfield, R Franklin, F J Macartney.   

Abstract

If cross sectional echocardiography in isolation is used to diagnose critical left ventricular outflow obstruction in neonates, false positive and false negative diagnoses may result. Continuous wave Doppler velocimetry was used to measure blood flow velocity in the ascending and descending thoracic aorta in six neonates (aged less than 6 weeks) presenting with reduced or absent peripheral pulses in order to determine the important sites of obstruction. This technique demonstrated abnormal high velocity blood flow jets (three times higher than normal) in the ascending aorta in three patients with normal descending aortic flow velocity, suggesting aortic stenosis. In the other three patients velocity in the ascending aorta was normal but high in the descending aorta, suggesting coarctation. The Doppler diagnosis was confirmed in the five patients who required surgery. Two patients had residual high velocity jets after aortic valvotomy. Both had significant pressure gradients across the aortic valve at cardiac catheterisation with good agreement between actual gradients and those predicted by the Doppler technique. Thus a combined anatomical and physiological approach using cross sectional echocardiography and continuous wave Doppler velocimetry enables accurate non-invasive definition of the site of left ventricular outflow obstruction and may obviate the need for invasive investigation in these sick neonates.

Entities:  

Mesh:

Year:  1984        PMID: 6238613      PMCID: PMC481680          DOI: 10.1136/hrt.52.5.552

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  5 in total

1.  Indirect measurement of blood pressure in neonates and infants utilizing an automatic noninvasive oscillometric monitor.

Authors:  R H Friesen; J L Lichtor
Journal:  Anesth Analg       Date:  1981-10       Impact factor: 5.108

2.  Clinical evaluation of Dinamap 845 automated blood pressure recorder.

Authors:  J H Silas; A T Barker; L E Ramsay
Journal:  Br Heart J       Date:  1980-02

3.  Non-invasive assessment of aortic stenosis by Doppler ultrasound.

Authors:  L Hatle; B A Angelsen; A Tromsdal
Journal:  Br Heart J       Date:  1980-03

4.  Noninvasive assessment and differentiation of left ventricular outflow obstruction with Doppler ultrasound.

Authors:  L Hatle
Journal:  Circulation       Date:  1981-08       Impact factor: 29.690

5.  Management of critical aortic stenosis in infancy.

Authors:  J D Sink; J F Smallhorn; F J Macartney; J F Taylor; J Stark; M R de Leval
Journal:  J Thorac Cardiovasc Surg       Date:  1984-01       Impact factor: 5.209

  5 in total
  6 in total

Review 1.  Ultrasound and coarctation of the aorta.

Authors:  J L Gibbs
Journal:  Br Heart J       Date:  1990-08

2.  Estimation of Doppler gradients at rest and during exercise in patients with recoarctation of the aorta.

Authors:  D Teien; H Wendel; S Holm; M Hallberg
Journal:  Br Heart J       Date:  1991-03

3.  Continuous wave Doppler echocardiography and coarctation of the aorta: gradients and flow patterns in the assessment of severity.

Authors:  J S Carvalho; A N Redington; E A Shinebourne; M L Rigby; D Gibson
Journal:  Br Heart J       Date:  1990-08

4.  Juxtaductal aortic atresia masquerading as coarctation.

Authors:  O Onuzo; M Rigby; A Redington
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

5.  Doppler ultrasound in the assessment of severity of coarctation of the aorta and interruption of the aortic arch.

Authors:  A B Houston; I A Simpson; J C Pollock; M P Jamieson; W B Doig; E N Coleman
Journal:  Br Heart J       Date:  1987-01

6.  Medical management of three asymptomatic infants with severe valvar aortic stenosis.

Authors:  W Berman; S M Yabek; R R Fripp; R Burstein; T Dillon; S Corlew
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.